A 3D multiscale model of cancer stem cell in tumor development

BMC Systems Biology

Volumn 7, Issue , 2013, Pages

  Li, Fuhai ^a   Tan, Hua ^a,b   Singh, Jaykrishna ^a   Yang, Jian ^a   Xia, Xiaofeng ^a   Bao, Jiguang ^b   Ma, Jinwen ^a,c   Zhan, Ming ^a   Wong, Stephen T C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BEIJING NORMAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGICAL MODEL; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; DRUG EFFECT; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOGENESIS; CELL DIFFERENTIATION; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; TREATMENT OUTCOME;

EID: 84904980165     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-S2-S12     Document Type: Article

References (33)

1. Gupta PB, Chaffer CL, Weinberg RA: Cancer stem cells: mirage or reality? Nat Med 2009, 15(9):1010-1012
2. Nguyen LV, Vanner R, Dirks P, Eaves CJ: Cancer stem cells: an evolving concept. Nat Rev Cancer 2012, 12(2):133-143
3. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3(7):730-737
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003, 100(7):3983-3988
5. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445(7123):106-110
6. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3(12):895-902
7. Huntly BJ, Gilliland DG: Cancer biology: summing up cancer stem cells. Nature 2005, 435(7046):1169-1170
8. Rich JN: Cancer stem cells in radiation resistance. Cancer Res 2007, 67(19):8980-8984
9. Zhang M, Atkinson RL, Rosen JM: Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci USA 2010, 107(8):3522-3527
10. Horst D, Chen J, Morikawa T, Ogino S, Kirchner T, Shivdasani RA: Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. Cancer Res 2012, 72(6):1547-1556
11. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010, 12(5):468-476
12. Anderson AR: A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005, 22(2):163-186
13. Kansal AR, Torquato S, Harsh GI, Chiocca EA, Deisboeck TS: Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. J Theor Biol 2000, 203(4):367-382
14. Bauer AL, Jackson TL, Jiang Y: A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J 2007, 92(9):3105-3121
15. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, Cristini V: An integrated computational/experimental model of tumor invasion. Cancer Res 2006, 66(3):1597-1604
16. Frieboes HB, Lowengrub JS, Wise S, Zheng X, Macklin P, Bearer EL, Cristini V: Computer simulation of glioma growth and morphology. Neuroimage 2007, 37(Suppl 1):S59-70
17. Zhu X, Zhou X, Lewis MT, Xia L, Wong S: Cancer stem cell, niche and EGFR decide tumor development and treatment response: A biocomputational simulation study. J Theor Biol 2011, 269(1):138-149
18. Ganguly R, Puri IK: Mathematical model for the cancer stem cell hypothesis. Cell Prolif 2006, 39(1):3-14
19. Michor F: Mathematical models of cancer stem cells. J Clin Oncol 2008, 26(17):2854-2861
20. Sottoriva A, Verhoeff JJC, Borovski T, McWeeney SK, Naumov L, Medema JP, Sloot PMA, Vermeulen L: Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity. Cancer Research 2010, 70(1):46-56
21. Tan H, Li F, Singh J, Xia X, Cridebring D, Yang J, Zhan M, Wong S, Bao J, Ma J: A 3-dimentional multiscale model to simulate tumor progression in response to interactions between cancer stem cells and tumor microenvironmental factors. 2012 IEEE 6th International Conference on Systems Biology (ISB) 18-20 Aug. 2012 2012 2012, 297-303
22. Hori K, Suzuki M, Abe I, Saito S: Increased tumor tissue pressure in association with the growth of rat tumors. Jpn J Cancer Res 1986, 77(1):65-73
23. Morrison SJ, Kimble J: Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441(7097):1068-1074
24. Dingli D, Traulsen A, Michor F: (A)symmetric stem cell replication and cancer. PLoS Comput Biol 2007, 3(3):e53
25. Zheng X, Wise SM, Cristini V: Nonlinear simulation of tumor necrosis, neovascularization and tissue invasion via an adaptive finite-element/levelset method. Bull Math Biol 2005, 67(2):211-259
26. Macklin P, McDougall S, Anderson AR, Chaplain MA, Cristini V, Lowengrub J: Multiscale modelling and nonlinear simulation of vascular tumour growth. J Math Biol 2009, 58(4-5):765-798
27. Truskey G, Yuan F, Katz D: Transport Phenomena in Biological Systems. Pearson Prentice Hall, Upper Saddle River, NJ 2004
28. Gockenbach MS: Understanding and implementing the finite element method. Philadelphia: Society for Industrial and Applied Mathematics 2006
29. Shu SGaC: Total variation diminishing runge-kutta schemes. Mathematics of computation 1998, 67:73-85
30. Weissman IL: Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000, 100(1):157-168
31. Norton L: A Gompertzian model of human breast cancer growth. Cancer Res 1988, 48(24 Pt 1):7067-7071
32. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, Casanovas O: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15(3):220-231
33. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15(3):232-239